MARKET

OMIC

OMIC

Singular Genomics Systems, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

11.81
-0.56
-4.53%
After Hours: 11.81 0 0.00% 16:23 09/24 EDT
OPEN
12.37
PREV CLOSE
12.37
HIGH
12.69
LOW
11.70
VOLUME
73.83K
TURNOVER
--
52 WEEK HIGH
33.37
52 WEEK LOW
11.70
MARKET CAP
845.08M
P/E (TTM)
-10.7647
1D
5D
1M
3M
1Y
5Y
Russell Microcap Index IPO additions
Russell Microcap Index adds IPO on a quarterly basis in addition to the annual reconstitution. The following tickers will be added effective Sept. 20 for Q3 Weber (NYSE:WEBR); Graphite Bio (NASDAQ:GRPH); 1stdibs.Com
Seekingalpha · 09/17 14:36
Do Insiders Own Lots Of Shares In Singular Genomics Systems, Inc. (NASDAQ:OMIC)?
If you want to know who really controls Singular Genomics Systems, Inc. ( NASDAQ:OMIC ), then you'll have to look at...
Simply Wall St. · 08/27 14:38
Deerfield Management Company, L.p. (series C) Buys Singular Genomics Systems Inc, CareMax Inc, ...
GuruFocus News · 08/24 19:38
Casdin Capital, LLC Buys Verve Therapeutics Inc, Century Therapeutics Inc, Singular Genomics ...
GuruFocus News · 08/24 14:38
60 Biggest Movers From Yesterday
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
Benzinga · 08/24 09:11
Singular Genomics Systems, Inc. to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
LA JOLLA, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today announced it will participate in a fireside chat at the UBS Genomic...
GlobeNewswire · 08/05 11:30
BRIEF-Singular Genomics Systems - Qtrly Basic And Diluted Net Loss Per Share $1.18
reuters.com · 08/03 11:40
Singular Genomics Systems EPS misses by $0.97
Singular Genomics Systems (NASDAQ:OMIC): Q2 GAAP EPS of -$1.18 misses by $0.97. Press Release
Seekingalpha · 08/03 11:19
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OMIC. Analyze the recent business situations of Singular Genomics Systems, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OMIC stock price target is 30.33 with a high estimate of 35.00 and a low estimate of 26.00.
EPS
Institutional Holdings
Institutions: 51
Institutional Holdings: 26.92M
% Owned: 37.62%
Shares Outstanding: 71.56M
TypeInstitutionsShares
Increased
0
0
New
51
26.92M
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About OMIC
Singular Genomics Systems, Inc. is a life science technology company that is leveraging next generation sequencing (NGS) and multiomics technologies to build products that supports researchers and clinicians. The Company has developed an NGS technology or sequencing engine. It is developing two integrated solutions that are built to target specific applications. The Company's first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which is collectively referred as G4 Integrated Solution. The G4 Instrument is a sequencer designed to produce accurate genetic sequencing results. Its second integrated solution in development comprises an instrument and an associated menu of consumable kits, which is collectively referred as PX Integrated Solution. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing multiomics solution.

Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OMIC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OMIC stock methods without spending real money on the virtual paper trading platform.